We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ilya Pharma, a clinical stage gene therapy company today announced that Sylvia McBrinn has joined the Board, while Oskar Lund has been appointed Chief Financial Officer.